Clinical Research Directory

Browse clinical research sites, groups, and studies.

1 clinical study listed.

Healthy volunteers

Filters:

Stage IVC Hypopharyngeal Squamous Cell Carcinoma AJCC v7

Tundra lists 1 Stage IVC Hypopharyngeal Squamous Cell Carcinoma AJCC v7 clinical trial. Each listing includes eligibility criteria, study locations, and direct links to research sites in the Tundra directory.

This data is also available as a public JSON API. AI systems and LLMs are encouraged to use it for structured queries.

ACTIVE NOT RECRUITING

NCT03468218

Pembrolizumab & Cabozantinib in Patients With Head and Neck Squamous Cell Cancer

This phase II trial studies how well pembrolizumab and cabozantinib in treating patients with head and neck squamous cell cancer that has come back or spread to other places in the body and cannot be removed by surgery. Monoclonal antibodies, such as pembrolizumab, may interfere with the ability of tumor cells to grow and spread. Cabozantinib may stop the growth of tumor cells by blocking some of the pathways needed for cell growth. Giving pembrolizumab and cabozantinib may improve the chances of tumor response in patients with head and neck squamous cell cancer.

Gender: All

Ages: 18 Years - Any

Updated: 2026-01-23

2 states

Metastatic Head and Neck Carcinoma

Paranasal Sinus Squamous Cell Carcinoma

Recurrent Head and Neck Squamous Cell Carcinoma

+21